CCNA2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.40739642162657E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.033500000025E-07 |
Normal-vs-Stage2 |
1.05230000002621E-06 |
Normal-vs-Stage3 |
1.09249997937155E-09 |
Normal-vs-Stage4 |
1.53089999566092E-08 |
Stage1-vs-Stage2 |
2.410200E-01 |
Stage1-vs-Stage3 |
6.039200E-03 |
Stage1-vs-Stage4 |
2.815600E-04 |
Stage2-vs-Stage3 |
1.785560E-01 |
Stage2-vs-Stage4 |
3.182400E-03 |
Stage3-vs-Stage4 |
3.088300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.51019255065921E-12 |
Normal-vs-AfricanAmerican |
5.72460000000108E-05 |
Normal-vs-Asian |
1.161620E-01 |
Caucasian-vs-AfricanAmerican |
9.794500E-04 |
Caucasian-vs-Asian |
4.390000E-01 |
AfricanAmerican-vs-Asian |
2.723600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.22972809291878E-12 |
Normal-vs-Female |
2.41540000223139E-08 |
Male-vs-Female |
1.428770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.044700E-04 |
Normal-vs-Age(41-60Yrs) |
6.75259959059815E-10 |
Normal-vs-Age(61-80Yrs) |
1.05469966094063E-10 |
Normal-vs-Age(81-100Yrs) |
4.258700E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.210400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.205600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.138400E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.786200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.478000E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.282300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.575900E-04 |
Normal-vs-Grade 2 |
4.5601000753237E-10 |
Normal-vs-Grade 3 |
1.92380000818559E-10 |
Normal-vs-Grade 4 |
1.07970000051694E-07 |
Grade 1-vs-Grade 2 |
1.782860E-03 |
Grade 1-vs-Grade 3 |
3.67869999999826E-05 |
Grade 1-vs-Grade 4 |
4.04230000000672E-05 |
Grade 2-vs-Grade 3 |
1.100240E-01 |
Grade 2-vs-Grade 4 |
9.590100E-04 |
Grade 3-vs-Grade 4 |
4.375100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.80090000023725E-07 |
Normal-vs-ccB subtype |
7.2946981788391E-11 |
ccA subtype-vs-ccB subtype |
1.075140E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.26839699538573E-11 |
Normal-vs-N1 |
2.559900E-04 |
N0-vs-N1 |
6.839900E-04 |
|
|